Clinical Trials Sponsored by Janssen-Cilag GmbH

Total 340 results

1
2
3
4
5
6
7
›

Janssen-Cilag International NV
Grünenthal GmbH

Completed

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo

Hallux Valgus

Taiwan
Janssen-Cilag Ltd.

Recruiting

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease (FUZION CD)

Fistulizing Crohns Disease | Perianal Crohns Disease

Netherlands, Belgium, Korea, Republic of, United States, Taiwan, Germany, Egypt, Israel, Canada, Hungary, Italy, Greece, Japan, Australia, Spain, Saudi Arabia, Poland, Turkey, United Kingdom, Jordan, Portugal, France, Czechia
Janssen-Cilag Ltd.

Completed

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment (ESCAPE-LTE)

Depressive Disorder, Major

Taiwan, Turkey, Malaysia, Germany, Korea, Republic of, Hungary, Argentina, Belgium, Bulgaria, Czechia, Finland, Greece, Poland, South Africa
Janssen-Cilag Ltd.

Withdrawn

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency (POWER)

Depressive Disorder, Major

United Kingdom
Janssen-Cilag Ltd.

Completed

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease (POWER)

Crohn Disease

United States, Korea, Republic of, Netherlands, France, Italy, United Kingdom, Austria, Germany, Russian Federation, Spain, Czechia, Sweden
Janssen-Cilag Ltd.

Completed

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab (STARDUST)

Crohn Disease

Belgium, Netherlands, United Kingdom, France, Czechia, Italy, Germany, Denmark, Spain, Portugal, Slovakia, Sweden
Janssen-Cilag Ltd.

Completed

A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation

Schizophrenia

France, Germany, Spain, Israel, Malaysia, Turkey, Taiwan, Greece, Korea, Republic of, Russian Federation, Netherlands, United Kingdom, Croatia, Denmark, Saudi Arabia
Janssen-Cilag S.p.A.

Completed

A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag (INSPECTIO)

Pulmonary Arterial Hypertension

Italy
Janssen-Cilag Ltd.

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice (FIRE)

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

France
Janssen-Cilag S.p.A.

Completed

A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy (ARIANNA)

Suicidal Ideation | Depressive Disorder, Major

Italy
Janssen-Cilag S.p.A.

Completed

A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs (SIRENA)

Spondyloarthritis, Axial and Peripheral

Italy
Janssen-Cilag Ltd.

Completed

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

Schizophrenia

France
Janssen-Cilag, S.A.

Terminated

Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar)

Rheumatoid Arthritis

Colombia
Janssen-Cilag Ltd.

Completed

An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection (MAPPING)

Hepatitis C Virus

Brazil
Janssen-Cilag Ltd.

Completed

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America (HOLA)

Lymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | Lymphoid

Argentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
Janssen-Cilag G.m.b.H

Completed

Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma

Multiple Myeloma

Germany
Janssen-Cilag, S.A.

Completed

Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia (PRE-COG)

Schizophrenia
Janssen-Cilag G.m.b.H

Terminated

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Schizophrenia

Germany
Janssen-Cilag, S.A.

Completed

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Vaginitis | Infectious Vaginosis

Mexico
Janssen-Cilag S.p.A.

Completed

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Human Immunodeficiency Virus; HIV
Janssen-Cilag Turkey

Completed

A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia

Schizophrenia

Turkey
Janssen-Cilag G.m.b.H

Terminated

A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain

Postoperative Pain

Germany
Janssen-Cilag S.p.A.

Completed

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder
Janssen-Cilag, S.A.

Completed

A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease
Janssen-Cilag Ltd.

Completed

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Child Behavior Disorders | Learning Disorders
Janssen-Cilag, S.A.

Completed

A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).

Pain
Janssen-Cilag, S.A.

Terminated

Safety of Rabeprazole in Patients Under Multiple Treatments

Gastroesophageal Reflux | Gastric Ulcer
Janssen-Cilag, S.A.

Terminated

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders
Janssen-Cilag S.p.A.

Completed

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Mental Disorders | Brain Diseases | Dementia | Alzheimer Disease
Janssen-Cilag B.V.

Completed

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Anemia | Neoplasm
Janssen Cilag S.A.S.

Recruiting

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia (QOLIBRI)

Leukemia, Lymphocytic, Chronic, B-Cell

France
Janssen Cilag S.A.S.

Completed

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases (TENOR)

Crohn Disease | Colitis, Ulcerative

France
Janssen-Cilag Ltd.

Completed

Treatment-Resistant Depression Cohort in Europe

Depressive Disorder, Treatment-Resistant

Portugal, Italy, Belgium, Germany, Spain, United Kingdom, Netherlands
Janssen-Cilag Ltd.

Completed

A Registry Study of Participants With Multiple Myeloma in Latin America (MYLACRE)

Multiple Myeloma

Brazil, Argentina, Mexico, Colombia, Panama
Janssen-Cilag, S.A.

Completed

Treatment Resistant Depression in America Latina (TRAL)

Depressive Disorder, Treatment-Resistant

Brazil, Argentina, Mexico, Colombia
Janssen-Cilag G.m.b.H

Completed

A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (POLARIS)

Psoriasis

Germany
Janssen-Cilag G.m.b.H

Completed

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) (PEPDar)

Human Immunodeficiency Virus (HIV)

Germany
Janssen-Cilag Ltd.

Completed

A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics (REALAI)

Schizophrenia

Mexico, Brazil
Janssen-Cilag B.V.

Completed

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Multiple Myeloma | Hematological Neoplasms

Netherlands
Janssen-Cilag G.m.b.H

Completed

A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

Multiple Myeloma

Germany
Janssen-Cilag, S.A.

Terminated

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Spain
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Janssen-Cilag S.p.A.

Completed

Survey on QUality of Life In myeloDisplasia (SQUID)

Myelodysplastic Syndromes
Janssen-Cilag B.V.

Completed

An Observational Study of Blood Management Techniques in Oncology Surgical Treatment

Neoplasms | Anemia | Blood Loss, Surgical

Netherlands
Janssen-Cilag G.m.b.H

Terminated

An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma

Lymphoma, Follicular

Germany
Janssen-Cilag B.V.

Completed

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Multiple Myeloma | Hematological Neoplasms

Netherlands
Janssen-Cilag S.p.A.

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients (MONARCH)

Human Immunodeficiency Virus 1
Janssen-Cilag S.p.A.

Completed

Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years

Schizophrenia
Janssen-Cilag, S.A.

Completed

FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

Schizophrenia
Janssen-Cilag, S.A.

Completed

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

Cancer Pain

1
2
3
4
5
6
7
›

3

Subscribe